Dexcom, Inc. 8-K Filing Insights: December 20, 2024 Report Overview
Based on the provided XML section from a financial report, here are the key insights extracted:
- Filing Information:
- Filing Type: 8-K
- Filing Date: December 20, 2024
- Company Information:
- Company Name: Dexcom, Inc.
- State of Incorporation: Delaware (DE)
- SEC Central Index Key (CIK): 0001093557
- IRS Employer Identification Number (EIN): 33-0857544
- Address: 6340 Sequence Drive, San Diego, CA 92121
- Phone Number: 858-200-0200
- Stock Information:
- Common Stock: $0.001 par value per share
- Ticker Symbol: DXCM
- Stock Exchange: NASDAQ
- Context Information:
- Period of Report: The report covers a single day, December 20, 2024.
- Miscellaneous:
- The XML snippet indicates that this is part of an XBRL (eXtensible Business Reporting Language) filing, which is commonly used for electronic financial reporting.
Insights:
- The filing of an 8-K typically indicates significant events that shareholders should be aware of, which may impact the company's financial condition or operations.
- The information confirms Dexcom, Inc.'s continued compliance with SEC reporting requirements and its active trading status on NASDAQ.
- The single-day reporting period implies that the filing likely pertains to a specific event or announcement made by the company on December 20, 2024, which would be relevant for investors and stakeholders.
These key points provide a high-level summary of the information contained in the financial report section provided.